Dr Reddy's Laboratories (RDY) Stock Research

Dr Reddy's Laboratories

· RDY

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

10.874 B

-1.79%

Monday

Dr. Reddy's double-upgraded to Buy from Sell at Citi

Sep 28, 9:25 PM

Over a week ago

Immutep provides update on development strategy for eftilagimod alfa

Sep 11, 8:14 AM

Dr. Reddy's says FDA inspection of UK facility 'officially closed'

Aug 14, 1:48 PM

Fresenius announces FDA approval of rituximab biosimilar

Aug 3, 4:14 PM

Innoviva announces distribution, licensing agreement with Dr. Reddy's

Jun 16, 8:06 AM

Dr. Reddy's announces first-to-market launch of Bosutinib Tablets 400mg

Jun 14, 5:09 PM

Alvotech resubmits AVT05 BLAs to FDA

Jun 4, 5:09 AM

Dr. Reddy's launches generic Semaglutide injection in Canada

May 17, 11:41 AM

Dr. Reddy's announces Health Canada approval for Semaglutide Injection

Apr 29, 7:40 AM

Goldman downgrades Dr. Reddy's to Sell on generic Ozempic concerns

Apr 23, 1:43 PM

Goldman Sachs gets more bearish on Dr. Reddy's, downgrades shares

Apr 23, 1:38 PM

Dr. Reddy's awaiting approval for Semaglutide in Canada, CNBC-TV18 says

Apr 23, 12:00 PM

Dr. Reddy's rally on CNBC report overstates upside, says Citi

Apr 23, 11:59 AM

Dr. Reddy's reports FDA acceptance to review Abatacept BLA

Feb 20, 10:58 AM

Coya Therapeutics to sell 2.522M shares at $4.40 in private placement

Jan 30, 8:13 AM

What You Missed On Wall Street On Monday

+33

Dec 8, 4:10 PM

Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.

+32

Dec 8, 11:58 AM

Immutep, Dr Reddy's enters strategic collaboration for Eftilagimod Alfa

Dec 8, 8:15 AM

What You Missed On Wall Street On Friday

+25

Oct 3, 4:32 PM

No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz

+25

Oct 3, 12:00 PM

Esperion reaches settlement agreement with ANDA filer, Dr. Reddy's

Oct 3, 8:01 AM

No more stories

Charts